Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report

Abu Baker Sheikh; Muhammad Ali Javaid; Abdul Ahad Ehsan Sheikh; Rahul Shekhar

doi:10.11604/pamj.2021.38.222.28243

Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report

Pan Afr Med J. 2021 Feb 26:38:222. doi: 10.11604/pamj.2021.38.222.28243. eCollection 2021.

Authors

Abu Baker Sheikh¹, Muhammad Ali Javaid², Abdul Ahad Ehsan Sheikh³, Rahul Shekhar⁴

Affiliations

¹ Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico (NM), USA.
² Department of Internal Medicine, Dow Medical College, Karachi, Pakistan.
³ Department of Internal Medicine, The Wright Center for Graduate Medical Education, Scranton, Pennsylvania (PA), USA.
⁴ Department of Internal Medicine, Division of Hospital Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico (NM), USA.

Abstract

SARS-CoV-2 infection, responsible for the coronavirus disease-2019 (COVID-19) has rapidly spread, causing a global pandemic. COVID-19 can affect any organ system in the body due to overwhelming dysregulated immune response and long-term effects of the disease is still unknown. Endocrine complications associated with COVID-19 is exceedingly rare. Here we present a unique case of a 44-year-old female who developed adrenal insufficiency and central diabetes insipidus following COVID-19 infection.

Keywords: COVID-19; case report; central adrenal insufficiency; central diabetes insipidus.

Copyright: Abu Baker Sheikh et al.

Publication types

Case Reports

MeSH terms

Adrenal Insufficiency / diagnosis*
Adrenal Insufficiency / virology
Adult
COVID-19 / complications*
Diabetes Insipidus / diagnosis*
Diabetes Insipidus / virology
Female
Humans